Rating Change
Oppenheimer analysts initiated coverage on PolyPid Ltd. (NASDAQ:PYPD) with a rating of Outperform on October 27, 2026.
new coverageNASDAQ:PYPD
Oppenheimer Initiates Coverage on PolyPid Ltd. (PYPD) with Outperform
Oppenheimer analysts initiated coverage on PolyPid Ltd. (NASDAQ:PYPD) with a rating of Outperform on October 27, 2026.
At publication ·
What changed
PolyPid Ltd. (NASDAQ:PYPD) · new coverage
- Firm
- Oppenheimer
- Rating
- Outperform
- Price at event
- $5.77
- Market capitalization
- $40.5M
At a glance
Key takeaways
- Oppenheimer initiated coverage of PolyPid Ltd. (PYPD) with an Outperform rating on October 27, 2026.
- The stock trades at $5.77 with a $40.5M market capitalization and has gained 53.8% over the past 52 weeks.
Market Context
PolyPid Ltd. operates in the Healthcare sector. The stock currently trades at $5.77 with a market capitalization of $40.5M. The stock has gained 53.8% over the past 52 weeks.
Analyst coverage from Oppenheimer provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for PolyPid Ltd.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for PolyPid Ltd.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 27, 2026 | Oppenheimer | Outperform | N/A |
| Jul 21, 2026 | HC Wainwright & Co. | Buy | N/A |
| Feb 11, 2026 | HC Wainwright & Co. | Buy | N/A |
| Nov 13, 2025 | Roth Capital | Buy | N/A |
| Aug 14, 2025 | Craig-Hallum | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View PYPD Stock Page
Frequently Asked Questions
What does the Outperform rating mean for PYPD?
A rating of Outperform from Oppenheimer reflects the analyst's outlook on PolyPid Ltd. (NASDAQ:PYPD). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PYPD forecast page.